Allergy

Autoimmune Diseases

Biosimilars

COVID-19

Cannabidiol (CBD)

Cardiology

Compounding

Continuous Glucose Monitoring

Dermatology

Diabetes

Digestive Health

Endocrinology

Eye Health

Generics

Headache and Migraine

Immunization

Infectious Disease

Influenza

Medical Devices

Mental and Behavioral Health

Neurology

Obesity Management

Oncology

Nonopioid Pain Management

Pain Management

Pediatrics

Pneumococcal

Public Health

Rare Diseases

Respiratory

Rheumatology

Shingles

Substance Use Disorder

Technology and Data

Veterinary Pharmacy 

Women's Health

News

FDA Updates

Law and Advocacy

Technology Trends

Viewpoints

All News

Media

In-Depth Insights

K-Casts

Script-Ed

Expert Interviews

Podcasts

Conferences

Conference Coverage

Conference Listing

Resources

Disease Awareness 

White Board Video

American Pharmacists Month

CME/CE

Partners

Publications

Drug Topics Journal

Total Pharmacy Journal

Submission of Articles

Events

Virtual Events

Total Pharmacy Solutions Summit

Business

Business Strategies

Patient Services

Pharmacy Inventory

Law and Regulations

All Business News

Practice Type

Independent Pharmacy

Chain Pharmacy

Specialty Pharmacy

Health System Pharmacy

Pharmacy Technicians

Subscribe

Articles

Lydia Newsom, PharmD, discuses how pharmacists can support patients using GLP-1s.

Q&A: Pharmacists’ Role in GLP-1 Diet, Exercise Counseling

Hannah Dellabella is a contributing writer for 

. She holds an MFA in creative writing from Purdue University and a BA in creative writing and professional writing from Carnegie Mellon University. She has previously worked as a medical writer and associate editor at Haymarket Media, and her work has also appeared in various literary magazines.

Discontinuing SSRIs or SNRIs during pregnancy did not lead to an increase in hospitalizations, outpatient visits, suicidal behavior, or sick leave use.

Stopping SSRIs, SNRIs During Pregnancy Not Linked to Adverse Psychiatric Outcomes

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists and patients view injectable contraception.

Q&A: Community Pharmacists Well-Positioned to Provide Injectable Contraception

Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.

What is Being Done to Address Pharmacy Deserts in the US?

About

Advertise

Editorial

Editorial Board

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Drug Topics

Facebook

LinkedIn

Spotlight

APhA Annual Meeting

1rem

View

Click the link below to register for the Total Pharmacy® Solutions Summit June Summit:

https://web.cvent.com/event/92dd9c48-442f-4567-89ef-51ea879c48fb/summary 

Total Pharmacy® Solutions Summit: June 14th 2025